Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: The XCELL trial

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 6, 2012, Pages 1042-1051

  Rocha Singh, Krishna J ^a   Jaff, Michael ^b   Joye, James ^c   Laird, John ^d   Ansel, Gary ^e   Schneider, Peter ^f  

^a ST JOHN'S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c EL CAMINO HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Riverside Hospital   (United States)

^f KAISER PERMANENTE   (United States)

Author keywords

critical limb ischemia; infrapopliteal; peripheral vascular disease; stents

Indexed keywords

ADULT; AGED; ANALGESIA; ANKLE BRACHIAL INDEX; ARTERY LESION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; LEG AMPUTATION; LEG ANGIOGRAPHY; LEG PAIN; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NITINOL STENT; PAIN ASSESSMENT; PATIENT SAFETY; POPLITEAL ARTERY; PROSPECTIVE STUDY; REVASCULARIZATION; SELF EXPANDING STENT; SURVIVAL TIME; TREATMENT OUTCOME; VASCULAR PATENCY; WOUND HEALING;

AGED; AGED, 80 AND OVER; ALLOYS; AMPUTATION; ANGIOPLASTY, BALLOON; CONSTRICTION, PATHOLOGIC; CRITICAL ILLNESS; FEMALE; HUMANS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOWER EXTREMITY; MALE; PAIN; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR PATENCY; WOUND HEALING;

EID: 84869504371     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24485     Document Type: Article

References (29)

1. Norgen L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, Rutherford RB,; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33: S1-S75.
2. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, Creager MA, Easton JD, Gavin JR III, Greenland P, Hankey G, Hanrath P, Hirsch AT, Meyer J, Jurgen, Smith SC, Sullivan F, Weber MA,. Prevention of atherothrombotic disease network. Critical issues in peripheral arterial disease detection and management: A call to action. Arch Int Med 2003; 163: 884-892.
3. Hirsch AT, Haskal ZJ, Hirtzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Tayor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Givvons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato FP, Page RL, Riegal B,. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to develop guidelines for the management of patients with peripheral arterial disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1-192.
4. Gray B, Conte M, Dake M, Jaff MR, Kandarpa K, Ramee SR, Rundback J, Waksman R,; Writing Group 7. Atherosclerotic peripheral vascular disease symposium II. Circulation 2008; 118: 2864-2872.
5. Yost ML,. Peripheral Arterial Disease: A Report by the Sage Group. 2004. Vol. II. Available online at www.thesagegroup.us.
6. Centers for Disease Control and Prevention. Number of people with diabetes increases to 24 million. Available at: http://www.cdc.gov/media/ pressrel/2008/r080624.htm. Last accessed on: February 27, 2011. (Press release).
7. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T,. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia. Circulation 2001; 104: 2057-2062.
8. Romiti M, Albers M, Brochado-Neto FC, Durrazzo AES, Pereira CAB, De Luccia N,. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47: 975-981.
9. Kudo T, Chandra F, Ahn SS,. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia. J Vasc Surg 2005; 41: 423-435.
10. Adam DJ, Beard JD, Cleveland T,; BASIL Trial Participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet 2005; 366: 1925-1934.
11. Biondi-Zoccai GGL, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, Agostoni P, Bosiers M, Peregrin J, Rosales O, Cotroneo AR, Rand T, Sheiban I,. Infra-genicular stent implantation for below-the-knee atherosclerotic disease: Clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009; 16: 251-259.
12. Bosiers M, Deloose K, Verbist J, Peeters P,. Nitinol stenting for the treatment of "below-the-knee" critical limb ischemia: 1-Year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg 2007; 48: 455-461.
13. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G,; VIVA Physicians, Inc. Performance goals and endpoint assessments for clinical trials of bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 2007; 69: 910-919.
14. Jensen MP, Karoly P, O'Riordan EF, Bland F, Burns RS,. The subjective experience of acute pain, an assessment of the utility of 10 indices. Clin J Pain 1989; 5: 153-159.
15. DeLoach, LJ, Higgins, MS, Caplan AB, Stiff JL,. The visual analog scale in the immediate postoperative period: Intrasubject variability and correlation with a numeric scale. Anesth Analg 1998; 86: 102-106.
16. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, Nehler MR, Powell RJ, Sidawy AN,. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009; 50: 1462-1473.
17. Bosiers M, Lioupis C, Deloose K, Verbist J, Peeters P,. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular 2009; 17: 1-8.
18. Donas KP, Torsello G, Schwindt A, Schönefeld E, Boldt O, Pitoulias GA,. Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up. J Vasc Surg 2010; 52: 356-361.
19. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A, Tsolakis J,. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: Enduring 1-year angiographic and clinical benefit. J Endovasc Ther 2007; 14: 241-250.
20. Atar E, Avrahami R, Koganovich Y, Litvin S, Knizhnik M, Belenky A,. Infrapopliteal stenting with silicon carbide-coated stents in critical limb ischemia: A 12 month follow-up study. Isr Med Assoc J 2009; 11: 611-614.
21. Deloose K, Bosiers M, Peeters P,. One year outcome after primary stenting of infrapopliteal lesions with the chromis deep stent in the management of critical limb ischaemia. EuroIntervention 2009; 5: 318-324.
22. Balzer JO, Khan V, Thalhammer A, Vogl TJ, Lehnert T,. Below the knee PTA in critical limb ischemia results after 12 months: Single center experience. Eur J Radiol 2010; 75: 37-42.
23. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, Tsolakis J,. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: Analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009; 20: 1141-1150.
24. Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, Diehm C, Biamino G, Vermassen F, Scheinert D, van Sambeek MR, Schillinger M,. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 2007; 28: 798-805.
25. Kumar A, Brooks S, Cavanaugh K, Zuckerman B,. FDA prospective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009; 50: 1474-1476.
26. Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, Salter KD, Nehler MR,. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg 2006; 43: 1183-1190.
27. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, Fujita M, Tersashi H, Nagata S,. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv 2010; 5: 830-836.
28. Söderström M, Aho PS, Lepäntalo M, Albäck A,. The influence of the characteristics of ischemic tissue lesions on ulcer healing time after infrainguinal bypass for critical leg ischemia. J Vasc Surg 2009; 49: 932-937.
29. Söderström M, Arvela E, Albäck A, Aho PS, Lepäntalo M,. Healing of ischaemic tissue lesions after infrainguinal bypass surgery for critical leg ischaemia. Eur J Vasc Endovasc Surg 2008; 36: 90-95.